Merck signs up to $3.3 billion cancer drug deal with China-based LaNova
(Reuters) -Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and sell an experimental cancer drug, the two companies said on ...
Rotten Tomatoes1d
New Movies in Theaters (2024)
Best TV Shows of 2024: Best New Series to Watch Now Link to Best TV Shows of 2024: Best New Series to Watch Now What to Watch: In Theaters and On Streaming. Link to What to Watch: In Theaters and ...